Haemostatix's Series A Round

Haemostatix raised a round of funding on January 02, 2006.

Haemostatix is a biopharmaceutical company developing first-in-class therapies for the treatment of bleeding or 'haemostasis'. The company has pioneered a new approach to haemostasis based on targetin…

Articles about Haemostatix's Series A Round: